ArticleCase reports in endocrinology2024

A Case in Which HLA-DR4 is Involved in the Development of Complex Immune-Related Endocrinological Adverse Events following Combination Therapy with Nivolumab and Ipilimumab.

Yonekazu Kidawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.